A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

It is one of several such projects underway to investigate the effects of GLP-1 RAs in people with psychiatric illnesses and addiction. Importantly, said Agarwal, side effects and responses to ...

Women who have been prescribed Mounjaro are being advised to use a barrier form of contraception and not rely on oral ...

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

The MHRA issued the warning amid concerns that the medications may not be used safely. There have been previous reports ...

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.

Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...

GLP-1 medications can be life-changing for some people, but they're not a fit for everyone. Some patients don't lose as much weight as they’d hoped, and others have trouble staying on the medication ...

Use of GLP-1 RA might ameliorate some of these negative effects. Using the TriNetX database, Dr Shah and colleagues identified patients with prostate cancer with pre-existing type 2 diabetes who ...